Cisatracurium Besylate Injection
Product Images NDC 65145-137

This is a description of an injectable solution of Cisatracurium Besylate used as a paralyzing agent for intravenous use in ICU only. The solution is free from preservatives and is a single-dose vial of 20 ml which should be discarded if unused. The details of the 2D code for batch overprinting such as Sr. No, GTIN, lot number, and expiry date will be printed during online packing. There are warnings of facilities available for artificial respiration as it may cause respiratory arrest. The solution contains benzenesulfonic acid added to adjust pH and must be stored in carton at 2 - 8°C without freezing and protected from light. Finally, the manufacturer of the solution is Caplin Striles Limited based in Gummidipoondi, India.*

This text contains information about a medication called Cisatracurium Besylate Injection, USP, 10mg/5ml (2mg/mL). It is a paralyzing agent for intravenous injection and should be used with caution. The medication comes in a 5ml single-dose vial, with details such as the lot number and expiration date printed during online packing. The medication should be stored at 2°C to 8°C, protected from light and unused portions should be discarded. The text also recommends that respiratory facilities be immediately available for artificial respiration.*

CISATRACURIUM BESYLATE INJECTION, USP is a medication that acts as a paralyzing agent. It is important to note that it can cause respiratory arrest.*

This is a description of a medication package containing a 10 mL multiple-dose vial of Cisatracurium Besylate Injection. The medication is a paralyzing agent, and each mL contains 2 mg of cisatracurium and 0.9% w/v benzyl alcohol as a preservative. It is for intravenous injection only and must be used with caution, as it can cause respiratory arrest. The medication must be stored at 2° to 8°C (36° to 46°F) in the carton and protected from light. The package must be discarded by a certain date, and it is manufactured by Caplin Steriles Limited in Gummidipoondi, India.*

This is a description of Cisatracurium Besylate Injection, USP. It is a paralyzing agent that is for ICU use only and must be administered via intravenous injection. The medication comes in a single-dose vial of 20 mL, and any unused portion should be discarded. It is important to note that the medication can cause respiratory arrest and facilities must have artificial respiration immediately available. The medication should be stored at 2° to 8°C (36° to 46°F) and protected from light. Once removed from refrigeration, it should be used within 21 days, even if refrigerated again. The manufacturer is Caplin Steriles Limited located in India. There is no lot number or expiration date available in the text.*

This is a warning information about Cisatracurium Besylate, an injection that is a paralyzing agent and may cause respiratory arrest. Artificial respiration facilities must be available immediately. Each mL contains cisatracurium 2 mg equivalent to cisatracurium besylate 2.68 mg, sterile and non-pyrogenic. It is stored at 2° to 8°C and should be used within 21 days after removal from refrigeration, even if re-refrigerated. Discard the unused portion. This drug is manufactured by Caplin Steriles Limited located in Gummedipondi, India.*